Fund Strategy

EMBL Ventures is an independent venture capital investor that engages in the financing and development of first-in-class products and technologies in the healthcare sector. Based on a strong scientific pedigree, the Fund strategy combines the core competencies of "Pharma" and "Biotech" to arrive at a scalable investment model that seeks at creating commercial value.

"EMBL Ventures has played a crucial role in building Elara Pharmaceuticals from an academic project to an established Biotech company. The excellent support and access to their network has smoothed the process of building the company and its capabilities. I would certainly recommend anyone who is thinking of starting a company to get EMBL Ventures involved."

Joe Lewis, PhD; CEO, Elara Pharmaceuticals, Heidelberg